U.S. flag

An official website of the United States government

Filters

See more specimen types...
See more states

Other countries

See more countries

Results: 21 to 40 of 61

Tests names and labsConditionsGenes, analytes, and microbesMethods

Genetic Test for Spinocerebellar Ataxia Type 1 - SCA1

CGPP - Center for Predictive and Preventive Genetics IBMC - Institute for Cell and Molecular Biology
Portugal
11
  • D Deletion/duplication analysis

Spinocerebellar ataxia (one type)

Diagnostics Division CENTRE FOR DNA FINGERPRINTING AND DIAGNOSTICS
India
11
  • E Sequence analysis of select exons

Spinocerebellar Ataxia (SCA) Type 1

Duzen Laboratories Duzen BBAGUAS
Turkey
11
  • T Targeted variant analysis

SCA Panel (Type 1,2,3,6,7)

Duzen Laboratories Duzen BBAGUAS
Turkey
45
  • T Targeted variant analysis

Spinocerebellar Ataxia Type 1 Repeat Analysis

GeneDx
United States
11
  • T Targeted variant analysis

Spinocerebellar Ataxia Repeat Expansion Analysis

GeneDx
United States
66
  • T Targeted variant analysis

Xpanded Adult Movement Disorders Panel

GeneDx
United States
5473
  • C Sequence analysis of the entire coding region

Spinocerebellar Ataxia Expansion Panel

Greenwood Genetic Center Diagnostic Laboratories Greenwood Genetic Center
United States
55
  • E Sequence analysis of select exons

Spinocerebellar Ataxia Type 1 Expansion Analysis

Greenwood Genetic Center Diagnostic Laboratories Greenwood Genetic Center
United States
11
  • T Targeted variant analysis

Spinocerebellar Ataxia Type 1 Repeat Expasion Analysis (Prenatal Diagnosis)

Baylor Genetics
United States
11
  • T Targeted variant analysis

SCA1 (ATXN1) Genetic Testing  (Repeat expansion)

MNG Laboratories (Medical Neurogenetics, LLC.)
United States
11
  • E Sequence analysis of select exons

Spinocerebellar ataxia: Full gene sequencing panel

CEN4GEN Institute for Genomics and Molecular Diagnostics
Canada
3837
  • I Microsatellite instability testing (MSI)
  • C Sequence analysis of the entire coding region

Comprehensive Ataxia Repeat Expansion Panel (SCA 1, 2, 3, 6, 7, 8, 10, 12, 17, 36, DRPLA & FRDA)

MNG Laboratories (Medical Neurogenetics, LLC.)
United States
1212
  • T Targeted variant analysis

Ataxia Repeat Expansion Analysis

Fulgent Genetics
United States
1915
  • T Targeted variant analysis

ATXN1 (Spinocerebellar Ataxia Type 1) Repeat Expansion Analysis

Fulgent Genetics
United States
11
  • T Targeted variant analysis

Spinocerebellar ataxia type 1

Genetics Service Unit National Institute of Biomedical Genomics
India
11
  • T Targeted variant analysis

Spinocerebellar ataxia type 1

Molecular Genetics Laboratory North York General Hospital
Canada
11
  • T Targeted variant analysis

Comprehensive Spinocerebellar Ataxia Repeat Expansion Panel (SCA 1, 2, 3, 6, 7, 8, 10, 12, 17, 36 & DRPLA)

MNG Laboratories (Medical Neurogenetics, LLC.)
United States
1111
  • T Targeted variant analysis

SPINOCEREBELLAR ATAXIA (AUTOSOMAL DOMINANT) (SCAs)

Laboratorio de Genetica Clinica SL
Spain
1819
  • C Sequence analysis of the entire coding region
  • T Targeted variant analysis

Ataxia, Complete Dominant Evaluation

Athena Diagnostics
United States
3125
  • C Sequence analysis of the entire coding region
  • T Targeted variant analysis

Results: 21 to 40 of 61

IMPORTANT NOTE: NIH does not independently verify information submitted to the GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in the GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.